These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34094951)

  • 1.
    Li Y; Li F; Bai X; Li Y; Ni C; Zhao X; Zhang D
    Front Oncol; 2021; 11():658547. PubMed ID: 34094951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Jiao Y; Li Y; Liu S; Chen Q; Liu Y
    Onco Targets Ther; 2019; 12():4141-4152. PubMed ID: 31213833
    [No Abstract]   [Full Text] [Related]  

  • 4. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer.
    Wu A; Zhang S; Liu J; Huang Y; Deng W; Shu G; Yin G
    Front Genet; 2020; 11():705. PubMed ID: 32765584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mining the prognostic significance and immune infiltration of
    Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
    Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
    Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
    Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression landscape of FOXP3 and its prognostic value in breast cancer.
    Li J; Zhang X; Liu B; Shi C; Ma X; Ren S; Zhao X; Liu Y
    Ann Transl Med; 2022 Jul; 10(14):801. PubMed ID: 35965804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma.
    Chen G; Song H; Yang Z; Du T; Zheng Y; Lu Z; Zhang K; Wei D
    Front Oncol; 2022; 12():890193. PubMed ID: 35619903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma.
    Feng C; Jin X; Han Y; Guo R; Zou J; Li Y; Wang Y
    Med Sci Monit; 2020 Oct; 26():e926800. PubMed ID: 33099569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HMGB3 and its prognostic value in breast cancer.
    Zhou X; Zhang Q; Liang G; Liang X; Luo B
    Front Oncol; 2022; 12():1048921. PubMed ID: 36620553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration.
    Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G
    Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression and prognosis analysis of integrin subunit α3 (ITGA3) in papillary thyroid cancer.
    Ma JJ; Xiang C; Zhu HQ; Bai BL; Wang P; Zhao GA
    Heliyon; 2024 Jan; 10(1):e23163. PubMed ID: 38163190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of
    Zhang X; Zheng Y; Liu X; Wang K; Zhao H; Yin Y; Yu Y
    Ann Transl Med; 2022 Jan; 10(2):81. PubMed ID: 35282072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of SPOCK2 expression signature for high-grade serous ovarian cancer patients.
    Jiao M; Sun W; Li L; Li C; Zhou J; Li Q; Duan L
    Front Genet; 2022; 13():878123. PubMed ID: 36246613
    [No Abstract]   [Full Text] [Related]  

  • 18. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
    Ling J; Peng N; Luo L
    J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of PPL expression in ovarian cancer.
    Hua T; Zhao BB; Fan SB; Zhao CF; Kong YH; Tian RQ; Zhang BY
    Discov Oncol; 2022 May; 13(1):35. PubMed ID: 35612641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.